BUDIMEX/ PLBUDMX00013 /
28/08/2023 11:21:10 | Var. - | Volume | Denaro- | Lettera- | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
---|---|---|---|---|---|---|---|
460.69PLN | - | 40,000 Fatturato: 18.43 mill. |
-Quantità in denaro: - | -Quantità in lettera: - | 17.18 bill.PLN | 3.49% | 32.15 |
GlobeNewswire
17:06
ROSEN, THE FIRST FILING FIRM, Encourages AXT, Inc. Investors to Secure Counsel Before Important Dead...
GlobeNewswire
16:17
TUESDAY DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Akero Therapeutics, Inc. Investors...
GlobeNewswire
16:11
ROSEN, A TOP RANKED LAW FIRM, Encourages Altimmune, Inc. Investors to Secure Counsel Before Importan...
GlobeNewswire
16:00
SPR® Therapeutics Recognized as a Top Workplace in Northeast Ohio for the Third Year in a Row
GlobeNewswire
15:50
ENPH INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Enphase Energy, Inc. Investors ...
GlobeNewswire
15:48
PATH INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that UiPath, Inc. Investors with ...
GlobeNewswire
15:45
Deadline in 2 Days: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Class Action...
GlobeNewswire
15:00
ROSEN, A LEADING LAW FIRM, Encourages Enphase Energy, Inc. Investors to Secure Counsel Before Import...